mRNA Therapeutics Contract Development & Manufacturing Market Size, Share & Trends Report

mRNA Therapeutics Contract Development & Manufacturing Market Size, Share & Trends Analysis Report By Application (Viral Vaccines, Protein Replacement Therapies), By Indication, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-083-7
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2020 - 2021
Industry: Healthcare

Market Segmentation

MRNA Therapeutics Contract Development and Manufacturing (CDMO) Application Outlook (Revenue, USD Million, 2020 - 2030)
- Viral Vaccines
- Protein Replacement Therapies
- Cancer Immunotherapies
MRNA Therapeutics Contract Development and Manufacturing (CDMO) Indication Outlook (Revenue, USD Million, 2020 - 2030)
- Infectious Diseases
- Metabolic & Genetic Diseases
- Cardiovascular & Cerebrovascular Diseases
MRNA Therapeutics Contract Development and Manufacturing (CDMO) End-User Outlook (Revenue, USD Million,2020 - 2030)
- Biotech Companies
- Pharmaceutical companies
- Government & Academic Research Institutes
MRNA Therapeutics Contract Development and Manufacturing (CDMO) Regional Outlook (Revenue, USD Million, 2020 - 2030)
- North America
  - North America MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
    - Viral Vaccines
    - Protein Replacement Therapies
    - Cancer Immunotherapies
  - North America MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
    - Infectious Diseases
    - Metabolic & Genetic Diseases
    - Cardiovascular & Cerebrovascular Diseases
  - North America MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
    - Biotech Companies
    - Pharmaceutical companies
    - Government & Academic Research Institutes
  - U.S.
    - U.S. MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - U.S. MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - U.S. MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes
  - Canada
    - Canada MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - Canada MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - Canada MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes
- Europe
- Asia Pacific
  - Asia Pacific MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
    - Viral Vaccines
    - Protein Replacement Therapies
    - Cancer Immunotherapies
  - Asia Pacific MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
    - Infectious Diseases
    - Metabolic & Genetic Diseases
    - Cardiovascular & Cerebrovascular Diseases
  - Asia Pacific MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
    - Biotech Companies
    - Pharmaceutical companies
    - Government & Academic Research Institutes
  - China
    - China MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - China MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - China MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes
  - India
    - India MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - India MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - India MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes
  - Japan
    - Japan MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - Japan MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - Japan MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes
  - Australia
    - Australia MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - Australia MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - Australia MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes
  - Thailand
    - Thailand MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - Thailand MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - Thailand MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes
  - South Korea
    - South Korea MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - South Korea MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - South Korea MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes
- Latin America
- Middle East & Africa
  - Middle East & Africa MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
    - Viral Vaccines
    - Protein Replacement Therapies
    - Cancer Immunotherapies
  - Middle East & Africa MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
    - Infectious Diseases
    - Metabolic & Genetic Diseases
    - Cardiovascular & Cerebrovascular Diseases
  - Middle East & Africa MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
    - Biotech Companies
    - Pharmaceutical companies
    - Government & Academic Research Institutes
  - South Africa
    - South Africa MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - South Africa MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - South Africa MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes
  - Saudi Arabia
    - Saudi Arabia MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - Saudi Arabia MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - Saudi Arabia MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes
  - UAE
    - UAE MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - UAE MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - UAE MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes
  - Kuwait
    - Kuwait MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Application
      - Viral Vaccines
      - Protein Replacement Therapies
      - Cancer Immunotherapies
    - Kuwait MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By Indication
      - Infectious Diseases
      - Metabolic & Genetic Diseases
      - Cardiovascular & Cerebrovascular Diseases
    - Kuwait MRNA Therapeutics Contract Development and Manufacturing (CDMO) Market, By End-User
      - Biotech Companies
      - Pharmaceutical companies
      - Government & Academic Research Institutes

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2020 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.